Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: Their possible involvement in pathological processes

Pathology International

Volumn 60, Issue 1, 2010, Pages 27-34

  Ohnishi, Koji ^a   Komohara, Yoshihiro ^a   Sakashita, Naomi ^a   Iyama, Ken Ichi ^b   Murayama, Toshihiko ^c   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

CD163; Interleukin 10; Ki 67; Langerhans cell histiocytosis; Signal transducer and activator of transcription 3; Tumor associated macrophages

Indexed keywords

INTERLEUKIN 10; STAT3 PROTEIN;

ADULT; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT M; FEMALE; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LANGERHANS CELL; MACROPHAGE; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; TUMOR CELL;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; GIANT CELLS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INTERLEUKIN-10; MACROPHAGES; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STATIC ELECTRICITY;

EID: 73649106582     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02472.x     Document Type: Article

References (34)

1. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995 127 : 1 11.
2. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000 12 : 71 81.
3. De Panfilis G, Soligo D, Manara GC, Ferrari C, Torresani C. Adhesion molecules on the plasma membrane of epidermal cells. I. Human resting Langerhans cells express two members of the adherence-promoting CD11/CD18 family, namely, H-Mac-1 (CD11b/CD18) and gp 150,95 (CD11c/CD18). J Invest Dermatol 1989 93 : 60 69.
4. Ladisch S. Langerhans cell histiocytosis. Curr Opin Hematol 1998 5 : 54 8.
5. Bank MI, Rengtved P, Carstensen H, Petersen BL. Langerhans cell histiocytosis: An evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 2003 111 : 300 308.
6. Senechal B, Elain G, Jeziorski E et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med 2007 4 : 1374 1384.
7. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 1999 94 : 4195 4201.
8. Amir G, Weintraub M. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis. Pediatr Blood Cancer 2008 50 : 304 307.
9. Willman CL, Busque L, Griffith BB et al. Langerhans' cell histiocytosis (histiocytosis X) a clonal proliferative disease. N Engl J Med 1994 331 : 154 160.
10. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994 343 : 767 768.
11. da Costa CE, Annels NE, Faaij CM, Forsyth RG, Hogendoorn PC, Egeler RM. Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med 2005 201 : 687 693.
12. Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans' cell histiocytosis (histiocytosis X): Immunophenotype and growth fraction. Hum Pathol 1993 24 : 840 845.
13. Geissmann F, Lepelletier Y, Fraitag S et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001 97 : 1241 1248.
14. Walter S, Govoni D, Bottazzi B, Mantovani A. The role of macrophages in the regulation of primary tumor growth. Pathobiology 1991 59 : 239 242.
15. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006 25 : 315 322.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984 133 : 1710 1715.
17. Moestrup SK, Møller HJ. CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004 36 : 347 354.
18. Komohara Y, Hirahara J, Horikawa T et al. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006 54 : 763 771.
19. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 964.
20. Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression. Eur J Cancer 2004 40 : 1660 1667.
21. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004 172 : 567 576.
22. Xu W, Schlagwein N, Roos A, van den Berg TK, Daha MR, van Kooten C. Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 2007 37 : 1594 1599.
23. Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 2005 29 : 617 624.
24. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005 210 : 153 160.
25. Boland JM, Folpe AL, Hornick JL, Grogg KL. Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: Diagnostic and histogenetic implications. Am J Surg Pathol 2009 33 : 1225 1229.
26. Coury F, Annels N, Rivollier A et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 2008 14 : 81 7.
27. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008 216 : 15 24.
28. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 2009 59 : 300 305.
29. Wang JM, Griffin JD, Ramabaldi A, Chen ZG, Mantovani A. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 1988 141 : 575 579.
30. Lee CH, Espinosa I, Vrijaldenhoven S et al. Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 2008 14 : 1423 1430.
31. Li L, Shaw PE. Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J Biol Chem 2002 277 : 17 397 405.
32. Chen CL, Cen L, Kohout J et al. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer 2008 7 : 78.
33. O'Farrell AM, Parry DA, Zindy F et al. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol 2000 164 : 4607 4615.
34. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19 : 683 765.